Diclofenac induced hepatitis: 3 cases with features of autoimmune chronic active hepatitis

LJ Scully, D Clarke, RJ Barr - Digestive diseases and sciences, 1993 - Springer
Diclofenac is a frequently prescribed nonsteroidal antiinflammatory drug (NSAID). Significant
hepatotoxicity related to diclofenac may be more common than previously recognized, as …

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

…, P Michieletti, GY Minuk, CS Pappas, LJ Scully… - Hepatology, 1994 - journals.lww.com
Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal
amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile …

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

…, CN Ghent, GY Minuk, SC Pappas, LJ Scully… - Hepatology, 1996 - journals.lww.com
Abstract Treatment of patients with primary biliary cirrhosis (PBC) using ursodeoxycholic
acid (UDCA) leads to a reduction in serum bilirubin. The first objective of this study was to …

[PDF][PDF] Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon

JA McDonald, L Caruso, P Karayiannis, LJ Scully… - …, 1987 - Wiley Online Library
In a randomized controlled trial, 41 chronic hepatitis B virus carriers were allocated, by
opening numbered computerized randomization envelopes, to receive recombinant interferon‐…

Antiviral therapy in hepatitis B infection

HC Thomas, LJ Scully - British medical bulletin, 1985 - academic.oup.com
Studies of the mechanism of elimination of infected hepatocytes during the course of acute
type B hepatitis suggest that early in the infection, interferon is produced which stimulates an …

Early-onset autoimmune hepatitis is associated with a C4A gene deletion

LJ Scully, C Toze, DPS Sengar, R Goldstein - Gastroenterology, 1993 - Elsevier
Background: Autoimmune hepatitis is an immunologically mediated disorder with some
similarities to systemic lupus erythematosus, including an association with HLA-A1, B8, DR3. …

Liver fibrosis attributed to lipid lowering medications: two cases

Z Punthakee, LJ Scully, MM Guindi… - Journal of internal …, 2001 - Wiley Online Library
Punthakee Z, Scully LJ, Guindi MM, Ooi TC (Department of Medicine, Division of
Gastroenterology, Department of Pathology and the Laboratory of Medicine and the Division of …

Approaches to the treatment of hepatitis B virus and delta-related liver disease

HC Thomas, AML Lever, LJ Scully… - Seminars in liver …, 1986 - thieme-connect.com
In order to understand the mechanisms underlying the development of chronic hepatitis B
virus (HBV) infection and to develop methods of treatment, we must first understand how the …

Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti‐HBc positive individuals, using the polymerase chain reaction

LJ Scully, H Sung, R Pennie… - Journal of medical virology, 1994 - Wiley Online Library
Continuing hepatitis B virus (HBV) infection is normally associated with the presence of
hepatitis B surface antigen (HBsAg) in the serum. In spite of sensitive screening assays for …

Urticaria and acute hepatitis A virus infection.

LJ Scully, AE Ryan - American Journal of Gastroenterology …, 1993 - search.ebscohost.com
Urticaria has been described only rarely in patients with hepatitis A virus infection, although
its association with acute hepatitis B virus infection is well recognized. A young male …